We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
–
AUM
$7.62B
AUM Growth
+$501M
Cap. Flow
-$682M
Cap. Flow %
-8.96%
Top 10 Hldgs %
31.49%
Holding
3,289
New
550
Increased
1,163
Reduced
866
Closed
207

Top Buys

Rank Stock Value
1
IXUS icon
iShares Core MSCI Total International Stock ETF
IXUS
+$22.8M
2
BSCX icon
Invesco BulletShares 2033 Corporate Bond ETF
BSCX
+$20.2M
3
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$17.4M
4
ZM icon
Zoom
ZM
+$13.9M
5
IBMS
iShares iBonds Dec 2030 Term Muni Bond ETF
IBMS
+$11.2M

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$694M
2
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$21.4M
3
BSCR icon
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
+$15.8M
4
IBMO icon
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
+$10.4M
5
PYPL icon
PayPal
PYPL
+$8.41M

Sector Composition

Rank Sector Weight
1 Technology 12.31%
2 Financials 6.67%
3 Industrials 4.87%
4 Consumer Discretionary 3.57%
5 Healthcare 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMCL icon
2801
Omnicell
OMCL
$1.86B
$305 ﹤0.01%
+10
New +$307
SB icon
2802
Safe Bulkers
SB
$781M
$302 ﹤0.01%
+68
New +$288
ANIK icon
2803
Anika Therapeutics
ANIK
$199M
$301 ﹤0.01%
32
-12
-27% -$115
SMPL icon
2804
Simply Good Foods
SMPL
$904M
$298 ﹤0.01%
12
-473
-98% -$14K
BCBP icon
2805
BCB Bancorp
BCBP
$176M
$296 ﹤0.01%
+34
New +$297
TBPH icon
2806
Theravance Biopharma
TBPH
$874M
$292 ﹤0.01%
+20
New +$253
CDNA icon
2807
CareDx
CDNA
$1.92B
$291 ﹤0.01%
20
-91
-82% -$1.3K
CGEM icon
2808
Cullinan Oncology
CGEM
$1.05B
$291 ﹤0.01%
+49
New +$359
SCWO icon
2809
374Water
SCWO
$37.8M
$287 ﹤0.01%
100
– –
ONTF
2810
DELISTED
ON24
ONTF
$286 ﹤0.01%
+50
New +$269
SWBI icon
2811
Smith & Wesson
SWBI
$655M
$286 ﹤0.01%
29
-8
-22% -$68
NPKI
2812
NPK International
NPKI
$1.21B
$283 ﹤0.01%
+25
New +$244
ADTN icon
2813
Adtran
ADTN
$798M
$282 ﹤0.01%
30
+29
+2,900% +$270
LAB icon
2814
Standard BioTools
LAB
$326M
$280 ﹤0.01%
215
+2
+0.9% +$3
INGM
2815
Ingram Micro Holding
INGM
$6.78B
$280 ﹤0.01%
13
– –
MAPS
2816
DELISTED
WM TECHNOLOGY INC A
MAPS
$279 ﹤0.01%
+240
New +$259
LWAY icon
2817
Lifeway Foods
LWAY
$465M
$278 ﹤0.01%
10
+5
+100% +$141
DAWN
2818
DELISTED
Day One Biopharmaceuticals
DAWN
$275 ﹤0.01%
39
+36
+1,200% +$248
CSTL icon
2819
Castle Biosciences
CSTL
$749M
$274 ﹤0.01%
+12
New +$244
CHPT icon
2820
ChargePoint
CHPT
$133M
$273 ﹤0.01%
25
– –
CON
2821
Concentra Group Holdings
CON
$4.04B
$273 ﹤0.01%
+13
New +$277
CHMG icon
2822
Chemung Financial Corp
CHMG
$390M
$263 ﹤0.01%
5
+4
+400% +$209
EPSN icon
2823
Epsilon Energy
EPSN
$176M
$263 ﹤0.01%
+52
New +$315
UIS icon
2824
Unisys
UIS
$227M
$262 ﹤0.01%
67
-376
-85% -$1.52K
GLUE icon
2825
Monte Rosa Therapeutics
GLUE
$1.92B
$260 ﹤0.01%
35
+10
+40% +$53
111 112
113
114 115

Similar funds

HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

Clearstead Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Clearstead Advisors held 3,289 positions worth $7.62B, up 7% from $7.12B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors withdrew a net $682M in Q3 2025, closing 207 positions and reducing 866 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $694M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Clearstead Advisors opened a new position in Invesco BulletShares 2033 Corporate Bond ETF worth $20.4M.

  • Clearstead Advisors's largest Q3 2025 buy was Invesco BulletShares 2033 Corporate Bond ETF: 949,887 shares worth $20.4M.
  • Clearstead Advisors added most to iShares Core MSCI Total International Stock ETF in Q3 2025, an estimated $22.8M increase.
  • Clearstead Advisors's biggest Q3 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $21.4M.
  • Clearstead Advisors fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $694M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.62B portfolio in Q3 2025.
  • Clearstead Advisors opened 550 new positions and closed 207 in Q3 2025.
  • Clearstead Advisors's portfolio value rose 7% quarter-over-quarter to $7.62B.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.